Castleark Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36M | Sell |
77,840
-29,140
| -27% | -$1.26M | 0.1% | 151 |
|
|
2025
Q1 | $3.7M | Buy |
+106,980
| New | +$3.7M | 0.13% | 149 |
|
|
2022
Q4 | – | Sell |
-90,470
| Closed | -$899K | – | 287 |
|
|
2022
Q3 | $899K | Buy |
+90,470
| New | +$899K | 0.05% | 195 |
|
|
2021
Q3 | – | Sell |
-46,457
| Closed | -$2.83M | – | 334 |
|
|
2021
Q2 | $2.83M | Sell |
46,457
-60,053
| -56% | -$3.66M | 0.1% | 174 |
|
|
2021
Q1 | $6.56M | Buy |
+106,510
| New | +$6.56M | 0.24% | 119 |
|